XPC and malignant colon neoplasm: The altered expression of XPC may affect the sensitivity of DLD-1 colon cancer cells to etoposide by manipulating the glycolytic process, since cancer cells have the preference for acquiring cellular energy from aerobic glycolysis over the usual oxidative phosphorylation pathway.